SHARE
COPY LINK

COVID-19

What needs to happen before European countries lift coronavirus restrictions?

With signs in some European countries that the coronavirus pandemic may have reached a plateau, governments are looking at how to lift lockdown restrictions on their crippled businesses and restless populations.

What needs to happen before European countries lift coronavirus restrictions?
AFP

But what are the conditions that countries should meet before they can start safely easing these strict measures and return to some kind of normalcy?

Don't act too quickly

Experts fear that governments will bow to economic and social pressure to lift their lockdowns prematurely, and warn that such a move could allow COVID-19 to return.

“Lifting the restrictions too quickly could lead to a deadly resurgence,” World Health Organization chief Tedros Adhanom Ghebreyesus has said.

Christian Brechot, Institut Pasteur president and former head of French national medical research institute INSERM, said we must be “very humble and very careful” with a virus that many nations have already underestimated.

“It's not clear with a pandemic of this scale how everything can miraculously return to normal,” Brechot told France Info radio.

European nations begin lifting

Despite such advice, in the hardest-hit continent Europe — where more than 78,000 people have died from the virus — several countries have already started partially lifting confinement measures.

Germany, which has seen new cases drop and was already less affected than some of its neighbours, appeared Monday to be moving towards lifting restrictions in stages.

Austria will allow small businesses to reopen after the Easter break, believing it has sufficiently flattened its infection curve.

Denmark will reopen daycare nurseries, kindergartens and primary schools from April 15, while the Czech Republic has already begun to gradually ease restrictions, including opening some shops.

The countries are following in the footsteps of China, which has loosened its unprecedented lockdown on the city of Wuhan, where the coronavirus emerged in December, after the strict measures appeared to have paid off.

'Very high plateau'

Elsewhere in Europe, however, there are fewer signs that restrictions will soon ease.

Britain passed the grim milestone of 10,000 deaths on the weekend while France is expected to extend its lockdown for at least several weeks.

France's national health service director Jerome Salomon said a slight decrease in intensive care admissions was a “pale ray of sunshine,” adding that “a very high plateau” seemed to be setting in.

The continent's hardest-hit countries Italy and Spain also seem to have reached such a high plateau, with their daily death rates gradually falling.

But after such a devastating period, neither country is letting down its guard — Italy has extended its confinement measures until May 3, while Spain has done the same until April 25. Ireland, Portugal and Belgium have also extended their measures.

Gradual relaxation from mid-May?

“It's not when we have arrived at a plateau that we should lift confinement measures which have helped avoid massive congestion in hospitals,” said Antoine Flahault, a specialist in public health and epidemiology at the University of Geneva.

It must only happen “when we see a decline,” he told broadcaster France 2.

Researcher Brechot said he “hopes that from mid-May we will be in a situation of deceleration” which will allow a “gradual relaxation” of restrictions.

Jean-Francois Delfraissy, who leads the coronavirus science council advising the French government, said “we are not going to go from black to white, but from black to grey, with continued confinement”.

“We can start to discuss post-confinement, but the essential and principal factor is to pursue strict confinement for several weeks.”

Three conditions

Delfraissy said there were several prerequisites for lifting confinement measures.

First, there would need to be an established decline in the number of COVID-19 cases in intensive care.

This would give exhausted health workers a badly needed respite and allow hospitals to restock equipment and supplies.

The transmission rate of COVID-19 — the number of people an infected individual infects in turn — would need to have dropped below one, compared to 3.3 people at the start of the outbreak.

And finally there would need to be a sufficient number of masks to protect the populace and tests to closely monitor the virus's spread. 

For example in France, screening capacity would need to increase from the current 30,000 tests a day to 100,000 or even 150,000 a day by the end of April, Delfraissy said.

Unknowns

Of course, these conditions are subject to much uncertainty, including the possible development an app that uses smartphones to trace the contacts of infected people.

Mobile operators have already been providing location data to health researchers in France and Germany.

Another major unknown is the effect that summer has on slowing COVID-19's spread in the northern hemisphere. 

Respiratory viruses are generally less prevalent in warmer months — flu season is in winter — but will the coronavirus be the same?

“If there is no summer brake, then it will be more complicated” to lift confinement measures, said epidemiologist Flahault.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

HEALTH

Shortage of medicines in Spanish pharmacies grows by 150 percent

Spanish pharmacies are increasingly struggling to get the proper supply of certain medicines such as paediatric amoxicillin and some anti-diabetic drugs.

Shortage of medicines in Spanish pharmacies grows by 150 percent

In 2022 Spanish pharmacies experienced supply problems with 403 medicines, according to Spain’s General Council of Pharmaceutical Colleges (CGCOF).

Though this figure represents just 5 percent of the total 20,000 medicines sold in Spain, it is an increase of 150 percent compared to 2021 and represents what experts have deemed a “worrying” trend that is rising after two years of decline. The shortages last an average of four or five weeks.

This was the warning made by the CGCOF based on its data on the supply of medicines (CisMED), which is focused on ‘supply alert’ notices provided by almost 10,000 of the 22,000 pharmacies across Spain.

READ ALSO – Reader question: Are there limits on bringing medicines into Spain?

On average in 2022, more than 70 medicines were identified as suffering from shortages per week. The weekly average for 2021 was 28 incidents and in 2020 it was 41.

Of these shortages, experts say they are especially pronounced in medicines for the nervous system and cardiovascular groups, and “very significantly” pronounced with paediatric amoxicillin and some anti-diabetic drugs.

Medicines for the nervous system made up around 20 percent of the incidents, followed by cardiovascular therapeutics, with 19 percent, digestive 14 percent, and respiratory 13 percent.

READ ALSO: Pharmacies in Spain will be able to sell medical marijuana by the end of 2022

Call for calm

Stark as this statistic may seem out of context, however, it does not suggest that shelves in Spanish pharmacies are bare nor that Spaniards are being turned away by out-of-stock pharmacists.

Speaking at a press conference on Tuesday, President of the CGCOF, Jesús Aguilar, soothed fears by drawing distinctions between different types of shortages, one, he said, was “when there is none for anyone,” and the other a lack of supply “when there is none today but there will be tomorrow, or when there is none here but there is there”. 

Spain, he said, was suffering the second, adding that pharmacists can always replace or find alternative medicines. “Citizens have to be calm. It’s under control. We have the problem when it comes to looking for the medicine, not the citizens,” he added.

Causes

The causes of the shortages of certain medicines in Spain are various, but many stem from a combination of the centralised nature of production, meaning some medicines are produced only in certain parts of the world or even single factories, and a shortage of raw materials and packaging from Asian countries where production has been slow to recover from the pandemic shutdown, as well as the low price of medicines in Spain.

The issue is “a multifactorial problem that comes from problems with the increasingly globalised nature of drug manufacturing,” Aguilar said. “This supply problem has been affecting Spain for years, as well as the rest of Europe and the world.”

Farmahelp

To try and ease the supply shortages, the CGCOF has launched a new campaign to expand ‘Farmahelp’, a collaborative network of pharmacies that already has almost 6000 participating branches.

The Farmahelp app allows patients to find medicines in nearby pharmacies when they are unavailable and connects the pharmacy branches so they can update one another about the availability of medicines.

SHOW COMMENTS